Transcatheter Aortic Valve Implantation Improves Cardiac Sympathetic Nerve Activity on 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Severe Aortic Valve Stenosis

• Published in: Circulation Journal 2018/01/25, Vol.82(2), pp.579-585
• Main Authors: Sobajima, Mitsuo, Ueno, Hiroshi, Onoda, Hiroshi, Kuwahara, Hiroyuki, Tanaka, Shuhei, Ushijima, Ryuichi, Fukuda, Nobuyuki, Yokoyama, Shigeki, Nagura, Saori, Doi, Toshio, Yamashita, Akio, Fukahara, Kazuaki, Ito, Hisakatsu, Kinugawa, Koichiro
• Format: Article
• Language: English
• Subjects: 123I-metaiodobenzylguanidine (MIBG); Aortic valve stenosis; Cardiac sympathetic nerve activity; Transcatheter aortic valve implantation (TAVI)
• ISSN: 1346-9843; 1347-4820; 1347-4820
• DOI: 10.1253/circj.CJ-17-0817

Background:There is a consensus that overactivation of the cardiac sympathetic nervous system (CSN) proportionately increases the severity of heart failure and is accompanied by worse prognosis. Because it is unknown whether patients with aortic valve stenosis (AS) have similar CSN activation, we investigated the effect of transcatheter aortic valve implantation (TAVI).Methods and Results:We enrolled 31 consecutive patients with AS treated by TAVI. 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy was performed at baseline and at 2 weeks after TAVI. At baseline, the early heart-mediastinum ratio (H/M) was within normal limits (3.0±0.5), but the delayed H/M was low (2.6±0.6) and the washout rate (WR) was high (34±13%). WR negatively correlated with aortic valve area (r=−0.389, P